We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

Targeting Resistant Prostate Cancer With ATR and PARP Inhibition (TRAP Trial)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03787680
Recruitment Status : Active, not recruiting
First Posted : December 26, 2018
Last Update Posted : January 10, 2023
Information provided by (Responsible Party):
University of Michigan Rogel Cancer Center

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : February 2023
Estimated Study Completion Date : February 2027